E. Ur

发表

Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue.

P. Collingwood, P. Hollett, D. Cadigan, 1996, Clinical nuclear medicine.

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I‐metaiodobenzylguanidine

A. Grossman, J. Bomanji, K. Britton, 1993, Nuclear medicine communications.

Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I‐metaiodobenzylguanidine

A. Grossman, J. Bomanji, K. Britton, 1992, Nuclear medicine communications.

42. Imaging somatostatin receptor-positive neoplasms (SRPN) and their metastases with radiolabelled somatostatin analogues 123I Tyr-3-octreotide (TOCT) and 111In [DTPA-D-Phe1]-octreotide (DOCT)

A. Grossman, S. Mather, J. Bomanji, 1992 .

Pituitary imaging using a labelled somatostatin analogue in acromegaly

S. Mather, A. Grossman, J. Bomanji, 1992, Clinical endocrinology.

Effect of metyrapone on the pituitary-adrenal axis in depression: relation to dexamethasone suppressor status.

T. Dinan, A. Grossman, V. O’Keane, 1992, Neuroendocrinology.

Measurement of the Proton Structure Function F 2 (x; Q 2 ) in the Low X Region at Hera H1 Collaboration H1 Collaboration

I. Gorelov, S. Murray, H. Kolanoski, 1993 .

Deep Inelastic Scattering Events with a LargeRapidity Gap at HERAH 1 Collaboration

I. Gorelov, R. Horisberger, H. Kolanoski, 2007 .

Malignant prolactinoma with extracranial metastases: a report of three cases

John D. Walker, P. Sönksen, D. Lowe, 1993, Clinical endocrinology.

Observation of Hard Processes in Rapidity Gap

R. Horisberger, H. Kolanoski, R. Nahnhauer, 2007 .

Radiolabeled octreotide

S. Mather, J. Bomanji, D. Ellison, 1992, Cell Biophysics.

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.

R. Reznek, A. Grossman, J. Bomanji, 1993, Clinical radiology.

Growth in CHARGE association.

E. Ur, K. Blake, J. Kirk, 1993, Archives of disease in childhood.

Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophinreleasing hormone-41 in normal human subjects

A. Grossman, G. Besser, S. Tsagarakis, 1991 .

Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects.

A. Grossman, G. Besser, E. Ur, 1991, The Journal of endocrinology.

Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitide

A. Grossman, J. Wass, K. Britton, 1993, Clinical endocrinology.

First Measurement of theDeep { Inelastic Structureof Proton Di ractionH

A. B. Clegg, R. Horisberger, J. Katzy, 2007 .

TREATMENT OF MALIGNANT PHEOCHROMOCYTOMA, PARAGANGLIOMA AND CARCINOID-TUMORS WITH I-131 METAIODOBENZYLGUANIDINE

A. Grossman, J. Bomanji, K. Britton, 1993 .

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.

A. Grossman, S. Mather, J. Bomanji, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.